Polymeric nanoparticle‐based delivery of TRAIL DNA for cancer‐specific killing

Lack of specificity in cancer therapeutics severely limits the efficacy of many existing treatment modalities. The use of Tumor Necrosis Factor‐related Apoptosis‐Inducing Ligand (TRAIL) is of interest to the field due to this protein's ability to cause cell death specifically in cancer cells wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzeng, Stephany Y., Wilson, David R., Hansen, Sarah K., Quiñones‐Hinojosa, Alfredo, Green, Jordan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365091/
https://www.ncbi.nlm.nih.gov/pubmed/28349127
http://dx.doi.org/10.1002/btm2.10019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365091/
https://www.ncbi.nlm.nih.gov/pubmed/28349127
http://dx.doi.org/10.1002/btm2.10019

Ejemplares similares